课题基金 / 基金详情

Identifying Gut Microbiome Mediated Mechanisms for Diastolic Dysfunction Improvement After Bariatric Surgery

Identifying Gut Microbiome Mediated Mechanisms for Diastolic Dysfunction Improvement After Bariatric Surgery
确定肠道微生物介导的减肥手术后改善舒张功能障碍的机制
批准号:
10442822
负责人:
Tammy Lyn Kindel
金额:
$44.66万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-01 至 2027-05-31

项目摘要

项目成果

Tammy Lyn Kindel的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结
英文摘要
Project Summary Sleeve gastrectomy (SG), is a type of bariatric surgery, which improves obesity-related diastolic dysfunction, a hallmark finding of heart failure with preserved ejection fraction (HFpEF). As weight reduction through dieting and caloric restriction fails to improve cardiac function, this suggests a mechanism for diastolic function improvement initiated from the alteration in gastrointestinal anatomy after SG. The broad, long-term objective of this project is to explore if gut microbial changes after SG, lead to a bile acid pool rich in farnesoid X receptor (FXR) agonists, that mediate diastolic function improvements. In Specific Aim 1, we will test the hypothesis that the post-SG gut microbiome increases plasma bile acid FXR agonists as a mechanism for cardiac function improvement. Studies will be conducted utilizing fecal material transfer of SG mice as well as metagenomic sequence analysis of SG stool from rodents and humans to determine the transferable effect of the gut microbiome on the plasma BA pool and diastolic function. In Specific Aim 2, we will determine whether SG plasma decreases cardiomyocyte metabolic stress via FXR activation. Human and rodent cardiomyocyte cell lines will be engineered for regulated FXR expression to determine whether SG plasma reduces cardiac metabolic stress through FXR agonism. In Specific Aim 3, we will determine whether SG improves diastolic function through cardiomyocyte FXR signaling in vivo by performing surgery and assessing cardiac function in a cardiomyocyte-specific FXR knockout mouse model. We hypothesize that SG enhances FXR signaling through microbial-derived products to improve cardiac function. These findings will enhance our understanding of the mechanisms for diastolic recovery after bariatric surgery to develop novel surgical and non-surgical therapies for diastolic dysfunction and HFpEF which replicate the metabolic mechanisms generated by a SG.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Gut Microbiome Mediated Mechanisms for Diastolic Dysfunction Improvement After Bariatric Surgery
  • 批准号:
    10626829
  • 项目类别:
  • 资助金额:
    $44.06万
  • 财政年份:
    2022
  • 负责人:
    Tammy Lyn Kindel
  • 依托单位:
The role of GLP-1 in cardiac recovery after bariatric surgery in obesity-induced heart failure
  • 批准号:
    10320340
  • 项目类别:
  • 资助金额:
    $15.09万
  • 财政年份:
    2019
  • 负责人:
    Tammy Lyn Kindel
  • 依托单位:
The role of GLP-1 in cardiac recovery after bariatric surgery in obesity-induced heart failure
  • 批准号:
    10080367
  • 项目类别:
  • 资助金额:
    $15.09万
  • 财政年份:
    2019
  • 负责人:
    Tammy Lyn Kindel
  • 依托单位:
Is GIP Involved in the Resolution of Diabetes After Roux-en-y Gastric Bypass?
  • 批准号:
    7545584
  • 项目类别:
  • 资助金额:
    $5.85万
  • 财政年份:
    2008
  • 负责人:
    Tammy Lyn Kindel
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: